Author:
Knox Peter P.,Lukashev Eugene P.,Korvatovskii Boris N.,Seifullina Nuranija Kh.,Goryachev Sergey N.,Allakhverdiev Elvin S.,Paschenko Vladimir Z.
Subject
Biochemistry,General Medicine,Biochemistry, Genetics and Molecular Biology (miscellaneous),Biophysics,Geriatrics and Gerontology
Reference39 articles.
1. Jensen, B. O., Kleppe, R., Kopperud, R., and Nygaard, G. (2010) Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change, Platelets, 22, 8-19,
https://doi.org/10.3109/09537104.2010.517581.
2. Shalinsky, D. R., Andreef, M., and Howell, S. B. (1990) Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro, Cancer Res., 50, 7537-7543.
3. Iuliano, L., Colavita, A. R., Leo, R., Praticò, D., and Violi, F. (1997) Oxygen free radicals and platelet activation, Free Radic. Biol. Med., 22, 999-1006,
https://doi.org/10.1016/s0891-5849(96)00488-1.
4. Wessler, J. D., Grip, L. T., Mendell, J., and Giugliano, R. P. (2013) The P-glycoprotein transport system and cardiovascular drugs, J. Americ. Coll. Cardiol., 61, 2495-2502,
https://doi.org/10.1016/j.jacc.2013.02.058.
5. Aliter, K. F., and Al-Horani, R. A. (2021) Potential therapeutic benefits of dipyridamole in COVID-19 patients, Curr. Pharm. Des., 27, 866-875,
https://doi.org/10.2174/1381612826666201001125604.